183 related articles for article (PubMed ID: 31387806)
1. Prognostic value of osteopontin expression in esophageal squamous cell carcinoma: A meta-analysis.
Wang Y; Lu Y; Xu W; Wang Y; Wu Y; Che G
Pathol Res Pract; 2019 Oct; 215(10):152571. PubMed ID: 31387806
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of modified Glasgow prognostic score in patients with esophageal squamous cell cancer: a Meta-analysis.
Wang Y; Chen L; Wu Y; Li P; Che G
Nutr Cancer; 2020; 72(7):1146-1154. PubMed ID: 31617767
[No Abstract] [Full Text] [Related]
3. Prognostic significance of circulating microRNA-21 expression in esophageal, pancreatic and colorectal cancers; a systematic review and meta-analysis.
Guraya S
Int J Surg; 2018 Dec; 60():41-47. PubMed ID: 30336280
[TBL] [Abstract][Full Text] [Related]
4. C-Met as a potential novel prognostic marker in squamous cell carcinoma and adenocarcinoma of esophagus: evidence from a meta-analysis.
Ren JL; Wu HF; Wang WJ; Hu GM; Gu B; Zhang M; Wang YX
Panminerva Med; 2017 Mar; 59(1):97-106. PubMed ID: 27636117
[TBL] [Abstract][Full Text] [Related]
5. PRAF2 overexpression predicts poor prognosis and promotes tumorigenesis in esophageal squamous cell carcinoma.
Qian Z; Wei B; Zhou Y; Wang Q; Wang J; Sun Y; Gao Y; Chen X
BMC Cancer; 2019 Jun; 19(1):585. PubMed ID: 31200670
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated circular RNAs as novel biomarkers in esophageal squamous cell carcinoma: a meta-analysis.
Guo C; Mi J; Li H; Su P; Nie H
Cancer Med; 2021 Nov; 10(22):7895-7908. PubMed ID: 34704390
[TBL] [Abstract][Full Text] [Related]
7. High expression of HLA-DQA1 predicts poor outcome in patients with esophageal squamous cell carcinoma in Northern China.
Shen FF; Pan Y; Li JZ; Zhao F; Yang HJ; Li JK; Gao ZW; Su JF; Duan LJ; Lun SM; Zhang P; Tian LQ; Sun G; Huang D; Cao YT; Zhou FY
Medicine (Baltimore); 2019 Feb; 98(8):e14454. PubMed ID: 30813145
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of MicroRNAs in Esophageal Carcinoma: A Meta-Analysis.
Gao S; Zhao ZY; Zhang ZY; Zhang Y; Wu R
Clin Transl Gastroenterol; 2018 Nov; 9(11):203. PubMed ID: 30420592
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic significance of hypoxia-inducible factor-1α in esophageal squamous cell carcinoma: a meta-analysis.
Ping W; Sun W; Zu Y; Chen W; Fu X
Tumour Biol; 2014 May; 35(5):4401-9. PubMed ID: 24425106
[TBL] [Abstract][Full Text] [Related]
10. Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients.
Wang Y; Jiang Z; Xu C; Wang H; Tan L; Su J; Wang X; Jiang D; Hou Y; Song Q
BMC Cancer; 2019 Mar; 19(1):240. PubMed ID: 30885149
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of microvessel density in esophageal squamous cell carcinoma-a systematic review and meta-analysis.
Guo X; Meng X; Liu R
Pathol Res Pract; 2021 Nov; 227():153644. PubMed ID: 34634564
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of pre-treatment prognostic nutritional index in esophageal squamous cell carcinoma: A meta-analysis.
Li P; Wang X; Lai Y; Zhou K; Tang Y; Che G
Medicine (Baltimore); 2019 May; 98(22):e15280. PubMed ID: 31145271
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin expression in squamous cell cancer of the esophagus.
Wu IC; Wu MT; Chou SH; Yang SF; Goan YG; Lee JM; Chou YP; Bair MJ; Wang TE; Chen A; Chang WH; Kuo FC; Wu DC
World J Surg; 2008 Sep; 32(9):1989-95. PubMed ID: 18629582
[TBL] [Abstract][Full Text] [Related]
14. No significant association between PIK3CA mutation and survival of esophageal squamous cell carcinoma: A meta-analysis.
Ge XQ; Yang YZ; Li SS; Hou L; Ren JL; Yang KP; Fa XE
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):462-468. PubMed ID: 28585132
[TBL] [Abstract][Full Text] [Related]
15. The microRNA-375 as a potentially promising biomarker to predict the prognosis of patients with head and neck or esophageal squamous cell carcinoma: a meta-analysis.
Wang P; Xu L; Li L; Ren S; Tang J; Zhang M; Xu M
Eur Arch Otorhinolaryngol; 2019 Apr; 276(4):957-968. PubMed ID: 30747316
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of pretreatment systemic immune-inflammation index in Chinese esophageal squamous cell carcinoma patients receiving radical radiotherapy: A meta-analysis.
Zeng X; Ye L; Luo M; Zeng D; Chen Y
Medicine (Baltimore); 2023 Jun; 102(25):e34117. PubMed ID: 37352061
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of systemic immune-inflammation index in surgical esophageal cancer patients: An updated meta-analysis.
Li X; Zhang S; Lu J; Li C; Li N
Front Surg; 2022; 9():922595. PubMed ID: 36090319
[TBL] [Abstract][Full Text] [Related]
19. Overexpressed ostepontin-c as a potential biomarker for esophageal squamous cell carcinoma.
Zhang MX; Xu YJ; Zhu MC; Yan F
Asian Pac J Cancer Prev; 2013; 14(12):7315-9. PubMed ID: 24460294
[TBL] [Abstract][Full Text] [Related]
20. FOXM1: A potential indicator to predict lymphatic metastatic recurrence in stage IIA esophageal squamous cell carcinoma.
Xiao Z; Jia Y; Jiang W; Wang Z; Zhang Z; Gao Y
Thorac Cancer; 2018 Aug; 9(8):997-1004. PubMed ID: 29877046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
